• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

心脏移植术后肥厚型心肌病：单中心病例系列

Hypertrophic Cardiomyopathy After Heart Transplantation: A Single-Center Case Series.

作者信息

Gao Hans, Kransdorf Evan, Ebinger Joseph, Kittleson Michelle M

机构信息

Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

出版信息

JACC Case Rep. 2023 Apr 14;14:101825. doi: 10.1016/j.jaccas.2023.101825. eCollection 2023 May 17.

DOI:10.1016/j.jaccas.2023.101825
PMID:37077874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10107007/
Abstract

We present 3 heart transplant recipients who developed hypertrophic cardiomyopathy years after transplantation. In all 3 cases, the diagnosis was initially made based on echocardiography and confirmed using cardiac magnetic resonance imaging. ().

摘要

我们报告了3例心脏移植受者，他们在移植多年后发生了肥厚型心肌病。在所有3例病例中，最初均根据超声心动图做出诊断，并通过心脏磁共振成像得以证实。（）

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b5/10107007/8771138f999d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b5/10107007/8771138f999d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b5/10107007/8771138f999d/fx1.jpg

相似文献

1
Hypertrophic Cardiomyopathy After Heart Transplantation: A Single-Center Case Series.心脏移植术后肥厚型心肌病：单中心病例系列
JACC Case Rep. 2023 Apr 14;14:101825. doi: 10.1016/j.jaccas.2023.101825. eCollection 2023 May 17.
2
Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.心脏磁共振成像对肥厚型心肌病诊断的影响——10 年 1000 多例患者的经验。
Eur Radiol. 2021 Mar;31(3):1194-1205. doi: 10.1007/s00330-020-07207-8. Epub 2020 Sep 2.
3
The Ace of Spades: Apical Hypertrophic Cardiomyopathy in an African Male Patient.黑桃A：一名非洲男性患者的肥厚型心肌病
Cureus. 2022 Feb 23;14(2):e22514. doi: 10.7759/cureus.22514. eCollection 2022 Feb.
4
Cardiac Magnetic Resonance Imaging Features in Hypertrophic Cardiomyopathy Diagnosed at <21 Years of Age.21 岁以下诊断的肥厚型心肌病的心脏磁共振成像特征。
Am J Cardiol. 2020 Apr 15;125(8):1249-1255. doi: 10.1016/j.amjcard.2020.01.027. Epub 2020 Jan 28.
5
Magnetic resonance imaging in familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion and cardiac enzymes.家族性肥厚型心肌病伴铊灌注异常及心肌酶异常的磁共振成像
Jpn Circ J. 1988 May;52(5):395-400. doi: 10.1253/jcj.52.395.
6
Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy.中国肥厚型心肌病患者的临床特征及长期预后
Am J Med. 2004 Jan 1;116(1):19-23. doi: 10.1016/j.amjmed.2003.09.020.
7
[The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part I].[心血管磁共振成像在肥厚型心肌病诊断中的作用。第一部分]
Vnitr Lek. 2017 Spring;63(3):194-198.
8
Magnetic resonance imaging of hypertrophic cardiomyopathy: beyond left ventricular wall thickness.肥厚型心肌病的磁共振成像：超越左心室壁厚度
Can Assoc Radiol J. 2015 Feb;66(1):71-8. doi: 10.1016/j.carj.2014.07.005.
9
The use of contrast-enhanced transthoracic echocardiography for spiral-variant hypertrophic cardiomyopathy.对比增强经胸超声心动图在螺旋变异型肥厚型心肌病中的应用。
Echocardiography. 2020 Nov;37(11):1873-1876. doi: 10.1111/echo.14871. Epub 2020 Sep 28.
10
Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option.肥厚型心肌病的心脏移植：一种有效的治疗选择。
J Heart Lung Transplant. 2004 Apr;23(4):413-7. doi: 10.1016/S1053-2498(03)00225-0.

引用本文的文献

1
Mavacamten Safety and Efficacy in a Heart Transplant Patient Exhibiting Obstructive Hypertrophic Cardiomyopathy Phenotype.麦卡姆坦对一名表现为梗阻性肥厚型心肌病表型的心脏移植患者的安全性和有效性。
JACC Case Rep. 2024 Aug 21;29(16):102454. doi: 10.1016/j.jaccas.2024.102454.
2
An Unusual Presentation of Apical Hypertrophic Cardiomyopathy in an Orthotopic Heart Transplant Recipient.原位心脏移植受者中的心尖肥厚型心肌病的罕见表现。
Cureus. 2023 Aug 29;15(8):e44344. doi: 10.7759/cureus.44344. eCollection 2023 Aug.

本文引用的文献

1
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy.梗阻性肥厚型心肌病患者行室间隔减少术的肌球蛋白抑制治疗。
J Am Coll Cardiol. 2022 Jul 12;80(2):95-108. doi: 10.1016/j.jacc.2022.04.048.
2
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.肥厚型心肌病的诊断与评估：美国心脏病学会心血管造影与介入学会最新临床综述
J Am Coll Cardiol. 2022 Feb 1;79(4):372-389. doi: 10.1016/j.jacc.2021.12.002.
3
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
肥厚型心肌病罕见基因突变个体的表型表达和结局。
J Am Coll Cardiol. 2021 Sep 14;78(11):1097-1110. doi: 10.1016/j.jacc.2021.07.017.
4
Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study).依维莫司预防心脏移植后钙调神经磷酸酶抑制剂诱导的左心室肥厚（RADTAC 研究）。
JACC Heart Fail. 2021 Apr;9(4):301-313. doi: 10.1016/j.jchf.2021.01.007.
5
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病（EXPLORER-HCM）的随机、双盲、安慰剂对照、3 期临床试验
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29.
6
Pathogenesis of calcineurin inhibitor-induced hypertension.钙调神经磷酸酶抑制剂相关性高血压的发病机制。
J Nephrol. 2012 May-Jun;25(3):269-75. doi: 10.5301/jn.5000174.
7
The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011.国际心肺移植学会登记处：2011年第28份成人心脏移植报告
J Heart Lung Transplant. 2011 Oct;30(10):1078-94. doi: 10.1016/j.healun.2011.08.003.
8
Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients.西罗莫司影响心肌细胞，以减轻心脏移植受者的左心室质量。
Eur Heart J. 2008 Nov;29(22):2742-50. doi: 10.1093/eurheartj/ehn407. Epub 2008 Sep 11.
9
Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients.移植后1年出现严重左心室肥厚可预测心脏移植受者的死亡率。
J Heart Lung Transplant. 2007 Feb;26(2):145-51. doi: 10.1016/j.healun.2006.11.003.
10
Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha.
Circulation. 2001 Aug 7;104(6):676-81. doi: 10.1161/hc3101.093765.